Outlook Worse for Arthritic Women

SEPTEMBER 01, 2003

    Despite the fact that both men and women with early rheumatoid arthritis (RA) improve rapidly following treatment, women do not fare as well as men over time. Although drug therapy has proven effective at limiting joint pain in newly diagnosed RA patients, these patients still experience a decline in their functional abilities, said Thomas Skogh, PhD, from the University of Linkoping in Sweden. Although the men in his study had joint disease that was equal to if not worse than that of the women, the men showed ?signs of more pronounced improvement and a more favorable course than the women with regard to functional abilities,? he said.

    Dr. Skogh and his colleagues followed 284 patients with RA. They gauged the severity of the disease by a variety of factors, and they gave patients a special questionnaire to determine their functional ability. At the beginning of the study, men and women were equal in terms of functional ability. When the researchers tested the patients 1 and 2 years later, the women had experienced a greater drop in their abilities than the men, according to the results of the study, which was published in the Annals of the Rheumatic Diseases (July 2003).


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.